Abstract:Background: An appropriate regulatory system to ensure and promote the quality, safety, and efficacy of the products of traditional medicine (TM) and complementary medicine (CM) is critical to not only public health but also economic growth. The regulatory approach and evaluation standards for TM/CM products featured with a long history of use are yet to be developed. This study aims to investigate and compare the existing regulatory approaches for TM/CM products with a long history of use. Method: A mixed approach of documentary analysis involving official and legal documents from official websites, as well as a scoping review of scholarly work in scientific databases about regulatory systems of TM/CM products in China, Hong Kong, Taiwan, Japan, and Korea, was employed in this study and used for comparison. Results: For registration purposes, all five regulatory systems recognized the history of use as part of the totality of evidence when evaluating the safety and efficacy of TM/CM products with a long history of use. Generally, the list of classic formulas is predefined and bound to the formulas recommended in the prescribed list of ancient medical textbooks. Expedited pathways are usually in place and scientific data of nonclinical and clinical studies may be exempted. At the same time, additional restrictions with the scope of products constitute a comprehensive approach in the regulation. Quality assurance and postmarketing safety surveillance were found to be the major focus across the regulatory schemes investigated in this study. Conclusion: The regulatory systems investigated in this study allow less stringent registration requirements for TM/CM products featured with a long history of use, assuming safety and efficacy to be plausible based on historic use. Considering the safety and efficacy of these products, regulatory standards should emphasize the technical requirements for quality control and postmarket surveillance.

Comparison and Analysis of the Health Products Supervisions in China,Japan,USA and EU

Improvement and Analysis on China’s Current Food Safety Information Disclosure System

The Comparison and References of the Medical Device Manufacturers' Supervision and Management Between the USA and China

Comparison of Marketing Authorization System for Drug Wholesale Enterprises between China and America

Development Evolution and Analysis of Chinese Supervision System for Health Food

[Better medical devices regulations for better health care: enlightenment for medical devices regulatory reform in China, from experiences of the E.U. and the U.S.A]

Comparison of Drug Control Between China and USA

Advancing the Regulation of Traditional and Complementary Medicine Products: A Comparison of Five Regulatory Systems on Traditional Medicines with a Long History of Use

Comparative Analysis for the Institutions of the Adulterated and Misbranded Drug in China and USA

On China food safety supervision structure's perfection from comparative law

Discussion on Improvement of Healthcare Regulation in China

Comparative study on Government Regulation System of Food Safety

The Comparison Study on the Registration Systems of Laws and Regulations of Herbal Medicine in European Union and Traditional Chinese Medicine in China

A Legal Analysis on the Current Trade Status of Traditional Chinese Medicinal Product in the E.U. — From the Perspectives of WTO Law and E.U. Pharmaceutical Law

Analysis on Food Packaging Materials Laws and Regulations and Standards Between China and Some Developed Countries

Comparison of Chinese and American Regulations, Standards and Guidelines for Food Labels

Discrepancy of False Medical Advertisement Supervision Between China and the United States

A Study on Food Safety Supervision System in China:Based on the Perspective of International Comparison

Comparative Study on Legal Liabilities System for Drug Safety between Home and Abroad

The Pharmaceutical Quality Regulation Systems in European Union and Its Inspirations*

Comparison and research of law system of food-safety supervision between China and South Korea